Immunology, Immune system, Internal medicine, Cancer and Antigen are his primary areas of study. His biological study spans a wide range of topics, including Cytotoxic T cell, Lung cancer, Human leukocyte antigen and Protocol. His research investigates the connection between Cytotoxic T cell and topics such as Epitope that intersect with issues in Ipilimumab.
His work carried out in the field of Ipilimumab brings together such families of science as Pembrolizumab, Nivolumab and Talimogene laherparepvec. His research in Internal medicine intersects with topics in Placebo, Surgery and Oncology. His Surgery study frequently draws connections to other fields, such as Melanoma.
His scientific interests lie mostly in Internal medicine, Immunology, Oncology, Immune system and Cancer research. He combines subjects such as Surgery, Placebo and Melanoma with his study of Internal medicine. Christian H. Ottensmeier has researched Melanoma in several fields, including Gastroenterology and Clinical trial.
His work deals with themes such as Cancer and Cytotoxic T cell, which intersect with Immunology. His Oncology research includes elements of Carboplatin, Nivolumab, Phases of clinical research and Pathology. His Cancer research study combines topics in areas such as Lung cancer and Downregulation and upregulation.
Christian H. Ottensmeier spends much of his time researching Immune system, Immunology, Transcriptome, Cytotoxic T cell and Gene expression. His Immune system research includes themes of Cancer research, Antibody, Disease and Cell type. Immunology is closely attributed to Melanoma in his study.
His Transcriptome study incorporates themes from Chemokine and CD8. He focuses mostly in the field of Adjuvant, narrowing it down to matters related to Bevacizumab and, in some cases, Oncology. His research integrates issues of Lymphocyte and NY-ESO-1 in his study of Oncology.
Christian H. Ottensmeier mostly deals with Cytotoxic T cell, Immune system, Transcriptome, Gene expression and Severe acute respiratory syndrome coronavirus 2. His study focuses on the intersection of Cytotoxic T cell and fields such as CD8 with connections in the field of Glycolysis, T cell, Virus, Respiratory system and Cytotoxicity. His research is interdisciplinary, bridging the disciplines of Cancer research and Immune system.
Many of his studies on Transcriptome involve topics that are commonly interrelated, such as Immunology. His biological study deals with issues like Disease, which deal with fields such as Apoptosis. He usually deals with Gene expression and limits it to topics linked to Chemokine and Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma.
F. Stephen Hodi;Steven J. O'Day;David F. McDermott;Robert W. Weber.
The New England Journal of Medicine (2010)
Cancer classification using the Immunoscore: a worldwide task force
Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell.
Journal of Translational Medicine (2012)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan;Rachel Rosenthal;Crispin T. Hiley;Crispin T. Hiley;Andrew J. Rowan.
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf;Sabrina Kuttruff-Coqui;Katrin Frenzel;Valesca Bukur.
Neoantigen-directed immune escape in lung cancer evolution
Rachel Rosenthal;Rachel Rosenthal;Elizabeth Larose Cadieux;Roberto Salgado;Maise Al Bakir.
DNA vaccines: precision tools for activating effective immunity against cancer.
Jason Rice;Christian H. Ottensmeier;Freda K. Stevenson.
Nature Reviews Cancer (2008)
Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.
Pia Kvistborg;Daisy Philips;Sander Kelderman;Lois Hageman.
Science Translational Medicine (2014)
Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer
Anusha-Preethi Ganesan;James Clarke;James Clarke;Oliver Wood;Eva M Garrido-Martin.
Nature Immunology (2017)
Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
M J Ward;S M Thirdborough;T Mellows;C Riley.
British Journal of Cancer (2014)
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.
Frederick Arce Vargas;Andrew J.S. Furness;Andrew J.S. Furness;Isabelle Solomon;Kroopa Joshi;Kroopa Joshi.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: